C-Peptide and its intracellular signaling

Area of Science:

• Endocrinology and Metabolism
• Cellular and Molecular Biology

Background:

• C-peptide was historically considered biologically inert.
• Emerging evidence reveals C-peptide possesses significant biological activities.
• These activities suggest a protective role in diabetic complications.

Purpose of the Study:

• To investigate the biological effects of C-peptide.
• To explore C-peptide's potential in preventing diabetic microvascular complications.
• To understand the cellular mechanisms underlying C-peptide's actions.

Main Methods:

• In vitro and in vivo studies in diabetic models and patients.
• Analysis of C-peptide binding to various cell types.
• Investigation of downstream cell signaling pathways and gene transcription.
• Examination of C-peptide effects on kidney tubular cells and interactions with disease mediators.

Main Results:

• C-peptide exhibits definite biological effects in diabetes.
• C-peptide binds to cells and activates signaling pathways affecting cell phenotype, migration, growth, and survival.
• Kidney tubular cells show high C-peptide binding; C-peptide antagonizes TGF-β1 and TNF-α effects in diabetic nephropathy.
• Evidence suggests a specific G-protein-coupled receptor for C-peptide.

Conclusions:

• C-peptide demonstrates protective actions against diabetic microvascular complications.
• Its cellular activity profile supports its potential as a therapeutic agent for type 1 diabetes.
• Further research into C-peptide's receptor and mechanisms is warranted for therapeutic development.